Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar 23:10:1793-1801.
doi: 10.2147/OTT.S132503. eCollection 2017.

Associations of NQO1 C609T and NQO1 C465T polymorphisms with acute leukemia risk: a PRISMA-compliant meta-analysis

Hairong He  1 , Xiaoyu Zhai  2 , Xiaomin Liu  3 , Jie Zheng  1 , Yajing Zhai  4 , Fan Gao  1 , Yonghua Chen  5 , Jun Lu  1
Affiliations

Associations of NQO1 C609T and NQO1 C465T polymorphisms with acute leukemia risk: a PRISMA-compliant meta-analysis

Hairong He et al. Onco Targets Ther. .

Abstract

Objective: The NAD(P)H:quinone oxidoreductase (NQO1) C609T and C465T polymorphisms have been widely thought to be associated with the risk of acute leukemia (AL) in recent years, but the correlations are still unclear. A meta-analysis is generally acknowledged as one of the best methods for secondary research, and so it was applied in this study with the aim of elucidating how the NQO1 C609T and C465T polymorphisms are related to the risk of AL.

Methods: Relevant studies were searched in the PubMed, EMBASE, CNKI, and Wanfang databases, and the obtained data were analyzed using Stata (version 12.1). The allele-contrast model was applied, and odds ratios (ORs) with 95% confidence intervals (CIs) were used to evaluate relationship strengths. Meta-regression was used to identify sources of heterogeneity, and subgroup analyses were conducted. Publication bias was analyzed using funnel plots, with the trim-and-fill method used to analyze the effect of publication bias on pooled results. In addition, sensitivity analysis, the fail-safe number method, and cumulative analysis by publication year were performed to measure the stability of the obtained results.

Results: This meta-analysis included 28 relevant studies involving 5,953 patients and 8,667 controls. Overall, the C609T polymorphism was associated with the risk of acute lymphoblastic leukemia (ALL; OR =1.18, 95% CI =1.00-1.39, P=0.05). Meanwhile, race was found to be a potential source of heterogeneity for the relationship between the C609T polymorphism and acute myeloid leukemia (AML) risk, and the subgroup analysis identified the C609T polymorphism as a risk factor for AML in Asians (OR =1.34, 95% CI =1.03-1.74, P=0.03). The number of studies about C465T polymorphism was too small to pool the data.

Conclusion: There are increased risks of ALL in all subjects and of AML in Asians for carriers of the NQO1 C609T polymorphism. Further studies are needed to verify the associations of the C465T polymorphism with the risk of AL.

Keywords: ALL; AML; NQO1; polymorphism.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Flow diagram of the study selection process. Abbreviations: NQO1, NAD(P)H:quinone oxidoreductase; AL, acute leukemia; AML, acute myeloid leukemia; ALL, acute lymphoblastic leukemia.
Figure 2
Figure 2
The associations between NQO1 C609T and the ALL risk. (A) Calculated ORs and 95% CIs for the association. (B) Sensitivity analysis via deletion of each individual study. (C) Cumulative meta-analysis according to publication year. (D) Trim-and-fill plot to correct publication bias. Note: Weights are from random-effects analysis. Abbreviations: NQO1, NAD(P)H:quinone oxidoreductase; ALL, acute lymphoblastic leukemia; OR, odds ratio; CI, confidence interval.
Figure 3
Figure 3
The associations between NQO1 C609T and AML risk. (A) Calculated ORs and 95% CIs for the association. (B) Funnel plot for detecting publication bias. Note: Weights are from random-effects analysis. Abbreviations: NQO1, NAD(P)H:quinone oxidoreductase; AML, acute myeloid leukemia; OR, odds ratio; CI, confidence interval.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Seedhouse C, Bainton R, Lewis M, Harding A, Russell N, Das-Gupta E. The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia. Blood. 2002;100(10):3761–3766. - PubMed
    1. Jia MF, Xi YM, Shi XE, et al. Relationship of MPO and NQO1 gene polymorphisms with susceptibility to acute leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012;20(6):1336–1340. Chinese. - PubMed
    1. Bolufer P, Collado M, Barragán E, et al. The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia. Haematologica. 2007;92(3):308–314. - PubMed
    1. Li C, Liu Y, Wei S, Zhou Y. A meta-analysis of the association between NQO1 C609T variation and acute myeloid leukemia risk. Pediatr Blood Cancer. 2014;61(5):771–777. - PubMed
    1. Malik E, Cohen SB, Sahar D, Dann EJ, Rund D. The frequencies of NAD(P)H quinone oxidoreductase (NQO1) variant allele in Israeli ethnic groups and the relationship of NQO1*2 to adult acute myeloid leukemia in Israeli patients. Haematologica. 2006;91(7):956–959. - PubMed

LinkOut - more resources